Hepathromb (Heparin Sodium)

Hepathromb is used in clinical settings where anticoagulation is required to prevent or treat thrombotic events.

• Prevention of venous thromboembolism in patients undergoing surgery or immobilization.
• Management of acute coronary syndromes where clot formation is a risk.
• Adjunct therapy during hemodialysis to maintain circuit patency.
• Treatment of established deep vein thrombosis or pulmonary embolism under supervision.
• Prophylaxis of clot formation in patients with atrial fibrillation undergoing certain procedures.
• Support of anticoagulation during cardiopulmonary bypass when rapid reversal may be needed.

Side effects associated with heparin sodium, the active component of Hepathromb, vary in frequency and severity.

Common

• Minor bruising or bleeding at injection sites.
• Small hematomas.
• Mild thrombocytopenia (platelet count reduction).
• Nausea or mild headache.

Serious

• Major hemorrhage (internal or external).
• Heparin‑induced thrombocytopenia (HIT) with risk of thrombosis.
• Allergic reactions such as urticaria or anaphylaxis.
• Elevated liver enzymes indicating hepatic involvement.

When prescribing or administering Hepathromb, healthcare professionals should consider several precautionary measures to ensure patient safety.

• Assess baseline coagulation parameters and platelet count before initiation.
• Review patient history for bleeding disorders, recent surgery, or trauma.
• Monitor for signs of bleeding during therapy, especially in the gastrointestinal and intracranial regions.
• Adjust dose or discontinue if significant thrombocytopenia develops.
• Use caution in patients with renal or hepatic impairment, as drug clearance may be altered.
• Avoid use in pregnancy unless benefits outweigh risks, after specialist consultation.

Heparin sodium can interact with other medications, affecting its anticoagulant effect or increasing bleeding risk.

Avoid

• Concurrent use of other anticoagulants such as warfarin, direct oral anticoagulants, or low‑molecular‑weight heparins.
• Antiplatelet agents like clopidogrel or aspirin when combined may amplify bleeding.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that impair platelet function.

Use with caution

• Certain antibiotics (e.g., vancomycin) that may potentiate anticoagulation.
• Thrombolytic agents used in acute clot dissolution.
• High‑dose corticosteroids that can affect platelet stability.